Galena Biopharma (GALE) +11.7% premarket on news of the issuance of a key patent covering the use of its NeuVax product candidate for breast cancer patients having low-to-intermediate IHC levels, which represent a significant unmet medical need with as much as 80% of patients who do not qualify for Herceptin therapy.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at CNBC.com (May 21, 2014)
at CNBC.com (Apr 8, 2014)
at CNBC.com (Mar 17, 2014)
at MarketWatch.com (Mar 17, 2014)
at CNBC.com (Jan 16, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs